Clinical Trials
4 trialsNCT00628628 2013-08-01
Rasburicase in Patients at Risk for Tumor Lysis Syndrome
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00664144 2012-03-07
GRAAL2
Sanofi
Phase 2 Terminated
NCT00631579 2009-10-02
Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma
Sanofi
Phase 2 Completed
NCT00290992 2009-03-30
Rasburicase for Hyperuricemia
Sanofi
Phase 2 Completed